Related Experiment Video

Updated: Jul 12, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Computational modelling of ErbB family phosphorylation dynamics in response to transforming growth factor alpha and

B S Hendriks1, J Cook, J M Burke

  • 1Pathways Capability, AstraZenica R&D Boston, Waltham, MA 02451, USA.

Systems Biology
|September 21, 2006
PubMed

Insights

This study developed a computational model to understand ErbB receptor signaling. The model suggests that dephosphorylation, a key process in cancer, primarily occurs in endosomes, not the cell surface.

Area of Science:

  • Oncology
  • Cell Biology
  • Computational Biology

Background:

  • ErbB receptor family members are implicated in various cancers, including lung and breast cancer.
  • Targeting ErbB receptors offers therapeutic potential, but a deeper understanding of their signaling dynamics is needed for improved drug development.
  • Complexities in ErbB receptor dimerization, trafficking, and activation hinder prediction of drug intervention effects.

Purpose of the Study:

  • To develop a computational model for quantitatively analyzing ErbB receptor signaling dynamics.
  • To investigate the role of dephosphorylation compartmentalization in ErbB signaling pathways.
  • To provide insights into how drug interventions might affect ErbB signaling.

Main Methods:

  • Developed a computational model incorporating principles of ErbB receptor interaction, trafficking, phosphorylation, and dephosphorylation.
  • Utilized the model to test hypotheses concerning the localization of dephosphorylation.
  • Applied model results to experimental data on ErbB 1, ErbB2, and ErbB3 phosphorylation in H292 lung carcinoma cells.

Main Results:

  • The computational model successfully simulated ErbB receptor signaling pathways.
  • Model results supported the hypothesis that key dephosphorylation occurs in an intracellular, endosomal compartment.
  • Dephosphorylation activity was found to be less significant at the cell surface plasma membrane.

Conclusions:

  • Intracellular, endosomal dephosphorylation is a critical aspect of the ErbB signaling response to ligands.
  • Endocytic trafficking compartmentalization significantly influences ErbB signaling outcomes.
  • This systems biology approach offers a framework for understanding and potentially modulating ErbB-driven cancers.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...